Numsa investment co. plans to bring drugs from India, Russia to fight Covid-19 - Tim Modise interviews Khandani Msibi

Loading player...
In this interview with broadcaster Tim Modise, Khandani Msibi, CEO of Numsa Investment Company, talks about 3sixtyBiomedicine’s offering hope in fighting Covid19 by bringing Covid19 therapies Remdesevir from India and from Russia Avifavir to South Africa. He says the medications are likely to be made available in the country in two weeks. He also talks about the PPE-related corruption and the lost opportunity to empower black-owned businesses. Learn more about your ad choices. Visit megaphone.fm/adchoices
9 Aug 2020 8AM English South Africa Investing · Business News

Other recent episodes

The BizNews Edge: African Bank's Billion-Rand Acquisition Trap

African Bank swung to a loss of nearly a billion rand after a four-year spree of buying and bolting together three banks to build a full-service lender, and the bad debt charge is still climbing. The contrast is brutal: a focused platinum-and-chrome miner, Tharisa, is printing cash with profit up…
25 Jun 7AM 9 min

The BizNews Edge: Nedbank, Grindrod and the coal stock no one was watching

Nedbank confirmed its guidance this morning, and its East Africa deal is weeks from closing - a transformation most investors are still underpricing. Grindrod's Port of Maputo posted extraordinary volumes, but the share may already be priced for perfection. A small coal miner no one follows just disclosed an 1,800%…
24 Jun 8AM 26 min